Home of InterVac   International Vaccine Centre

Research and VIDO-InterVac

VIDO-InterVac’s research includes a broad range of infectious diseases and "platform technologies" applicable to a broad spectrum of diseases or species.

Our capabilities for testing vaccines against Containment Level 2 (CL2) diseases range from small rodent trials to large animal disease models.

When InterVac is operational in 2011, our capabilities will expand substantially to include Containment Level 3 diseases.

VIDO-InterVac research programs are organized into seven themed areas:

• Bacterial Vaccine Development
• Emerging Infectious Diseases and Microbial Virulence
• Immune Modulation
• Neonatal Immunization
• Pathogenomics
• Vectored Vaccines
• Viral Pathogenesis & Vaccine Development

Inquiries about research programs can be directed to Dr. Volker Gerdts, Associate Director for Research at (306) 966-1513 or volker.gerdts@usask.ca

Research Support Services

Successful research projects require organization-wide support and coordination.

Two key research support groups are:

• Chemical, Genomic, Glassware and Media Preparation Services 
• Clinical Research and Epidemiological Services

Other key teams supporting our research include:

• Business Development
• Finance and Administration
• Human Resources